Are Analysts Bearish Merit Medical Systems, Inc. (NASDAQ:MMSI) After Last Week?

December 8, 2017 - By Louis Casey

 Are Analysts Bearish Merit Medical Systems, Inc. (NASDAQ:MMSI) After Last Week?
Investors sentiment is 1.49 in 2017 Q2. Its the same as in 2017Q1. It is without change, as 19 investors sold Merit Medical Systems, Inc. shares while 52 reduced holdings. only 38 funds opened positions while 68 raised stakes. 44.02 million shares or 2.45% more from 42.97 million shares in 2017Q1 were reported.
Moreover, Century Mgmt Ltd Limited Liability Company has 0.54% invested in Merit Medical Systems, Inc. (NASDAQ:MMSI). Michigan-based Comerica Bancshares has invested 0.02% in Merit Medical Systems, Inc. (NASDAQ:MMSI). Ls Investment Advsrs Ltd has 0.01% invested in Merit Medical Systems, Inc. (NASDAQ:MMSI). Spark Mngmt Ltd Co invested in 0.07% or 29,900 shares. Swiss Retail Bank has invested 0% in Merit Medical Systems, Inc. (NASDAQ:MMSI). Gemmer Asset Management Limited Liability Co has 167 shares for 0% of their portfolio. Great West Life Assurance Com Can owns 72,856 shares or 0.01% of their US portfolio. State Of Alaska Department Of Revenue invested in 9,857 shares. First Tru L P has 0.01% invested in Merit Medical Systems, Inc. (NASDAQ:MMSI) for 63,853 shares. Blair William Il holds 0% or 15,399 shares. Geode Management Ltd Llc reported 0.01% in Merit Medical Systems, Inc. (NASDAQ:MMSI). Mufg Americas Holding Corporation holds 190 shares. Morgan Stanley reported 0% in Merit Medical Systems, Inc. (NASDAQ:MMSI). Alliancebernstein L P invested 0% in Merit Medical Systems, Inc. (NASDAQ:MMSI). Art Llc accumulated 29,300 shares or 0.06% of the stock.

Merit Medical Systems, Inc. (NASDAQ:MMSI) Ratings Coverage

Among 8 analysts covering Merit Medical (NASDAQ:MMSI), 8 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Merit Medical has $51.0 highest and $22 lowest target. $43.58’s average target is -0.62% below currents $43.85 stock price. Merit Medical had 17 analyst reports since October 23, 2015 according to SRatingsIntel. The rating was upgraded by Barrington Research on Monday, October 26 to “Outperform”. Bank of America initiated Merit Medical Systems, Inc. (NASDAQ:MMSI) on Thursday, July 20 with “Buy” rating. Canaccord Genuity initiated the shares of MMSI in report on Tuesday, July 19 with “Buy” rating. The company was downgraded on Friday, October 23 by Barrington Research. Canaccord Genuity maintained it with “Buy” rating and $3700 target in Monday, July 10 report. The company was maintained on Thursday, November 30 by Wells Fargo. The rating was maintained by Canaccord Genuity on Sunday, October 8 with “Buy”. The firm has “Buy” rating given on Thursday, July 27 by Canaccord Genuity. Canaccord Genuity maintained the stock with “Buy” rating in Thursday, November 16 report. Raymond James downgraded the stock to “Outperform” rating in Monday, August 28 report. Below is a list of Merit Medical Systems, Inc. (NASDAQ:MMSI) latest ratings and price target changes.

30/11/2017 Broker: Wells Fargo Rating: Buy New Target: $51.0 Maintain
16/11/2017 Broker: SunTrust Rating: Buy New Target: $47.0 Maintain
16/11/2017 Broker: Canaccord Genuity Rating: Buy New Target: $47.5 Maintain
26/10/2017 Broker: Canaccord Genuity Rating: Buy Old Target: $45 New Target: $47.5 Maintain
08/10/2017 Broker: Canaccord Genuity Rating: Buy New Target: $45.0 Maintain
04/09/2017 Broker: Canaccord Genuity Rating: Buy New Target: $45.0 Maintain
28/08/2017 Broker: Raymond James Old Rating: Strong Buy New Rating: Outperform Downgrade
27/07/2017 Broker: Craig Hallum Rating: Buy New Target: $50.0000 Maintain
27/07/2017 Broker: Canaccord Genuity Rating: Buy New Target: $45.0000 Maintain
20/07/2017 Broker: Bank of America Rating: Buy New Target: $44.0000 Initiate

The stock increased 1.39% or $0.6 during the last trading session, reaching $43.85. About 410,222 shares traded or 0.55% up from the average. Merit Medical Systems, Inc. (NASDAQ:MMSI) has risen 81.84% since December 8, 2016 and is uptrending. It has outperformed by 65.14% the S&P500.

Merit Medical Systems, Inc. designs, develops, makes, and markets medical products for interventional and diagnostic procedures worldwide. The company has market cap of $2.20 billion. The companyÂ’s Cardiovascular segment offers cardiology and radiology devices for diagnosing and treating coronary arterial, peripheral vascular, and other non-vascular diseases; and embolotherapeutic products. It has a 74.7 P/E ratio. It also provides vascular access products; guide wires, inflation devices, and diagnostic catheters for use in angiography procedures; therapeutic infusion systems and safety products; drainage catheters and drainage access products, support catheters, vascular retrieval devices, and dialysis access products; and embosphere microspheres and delivery systems, and microcatheters.

More notable recent Merit Medical Systems, Inc. (NASDAQ:MMSI) news were published by: Seekingalpha.com which released: “Merit Medical Systems’ (MMSI) CEO Fred Lampropoulos on Q2 2017 Results …” on July 27, 2017, also Seekingalpha.com with their article: “Merit Medical – Becton And Bard Deal Looks Nice” published on November 17, 2017, Globenewswire.com published: “Merit Medical Announces Appointment of New Director” on May 26, 2017. More interesting news about Merit Medical Systems, Inc. (NASDAQ:MMSI) were released by: Globenewswire.com and their article: “Merit Medical Systems to Announce Second Quarter Results on July 26, 2017” published on July 10, 2017 as well as Globenewswire.com‘s news article titled: “Merit Medical Systems to Announce Third Quarter Results on October 25, 2017” with publication date: October 12, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.